Ginkgo Bioworks Holdings, Inc. (DNA) has been on a downward spiral lately with significant selling pressure. After declining 28.8% over the past four weeks, the stock looks well positioned for a trend ...

In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) stands against other best gene-editing stocks to buy. Gene editing is an advanced medical technique ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $6.59, moving -0.9% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.33%.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Ginkgo Bioworks (DNA) announced a new contract with the Advanced Research Projects Agency for Health, or ARPA-H, alongside partners Tritica ...

Marie E. Fallon informed Ginkgo Bioworks (DNA) on May 1, 2023 of her intent to resign from her role as Chief Accounting Officer of... ByInvesting.com • May 05, 2023 Ginkgo Bioworks and Syngenta ...

Ginkgo Bioworks (DNA) is down -4.8%, or -27c to $5.39.Don't Miss Our End of Quarter Offers: Discover the latest stocks recommended by top Wall ...

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Founded in 2008, Ginkgo Bioworks is at the forefront of using biology to improve the world in multiple facets. DNA Articles 3 Stocks Hitting New 52-Week Lows.